- Home
- SCPH vs PAYS Comparison
SCPH vs PAYS Comparison
Compare SCPH & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- PAYS
- Stock Information
- Founded
- SCPH 2013
- PAYS 1995
- Country
- SCPH United States
- PAYS United States
- Employees
- SCPH N/A
- PAYS N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- PAYS Business Services
- Sector
- SCPH Health Care
- PAYS Consumer Discretionary
- Exchange
- SCPH Nasdaq
- PAYS Nasdaq
- Market Cap
- SCPH 179.6M
- PAYS 160.1M
- IPO Year
- SCPH 2017
- PAYS 1998
- Fundamental
- Price
- SCPH $3.24
- PAYS $2.90
- Analyst Decision
- SCPH Strong Buy
- PAYS Strong Buy
- Analyst Count
- SCPH 2
- PAYS 3
- Target Price
- SCPH $15.00
- PAYS $6.17
- AVG Volume (30 Days)
- SCPH 412.0K
- PAYS 348.4K
- Earning Date
- SCPH 03-12-2025
- PAYS 11-05-2024
- Dividend Yield
- SCPH N/A
- PAYS N/A
- EPS Growth
- SCPH N/A
- PAYS 368.11
- EPS
- SCPH N/A
- PAYS 0.14
- Revenue
- SCPH $30,278,000.00
- PAYS $56,467,600.00
- Revenue This Year
- SCPH $172.64
- PAYS $25.57
- Revenue Next Year
- SCPH $131.43
- PAYS $13.13
- P/E Ratio
- SCPH N/A
- PAYS $20.91
- Revenue Growth
- SCPH 303.87
- PAYS 27.75
- 52 Week Low
- SCPH $3.08
- PAYS $2.65
- 52 Week High
- SCPH $6.54
- PAYS $5.59
- Technical
- Relative Strength Index (RSI)
- SCPH 40.08
- PAYS 42.83
- Support Level
- SCPH $3.27
- PAYS $2.95
- Resistance Level
- SCPH $3.59
- PAYS $3.40
- Average True Range (ATR)
- SCPH 0.20
- PAYS 0.19
- MACD
- SCPH -0.01
- PAYS 0.02
- Stochastic Oscillator
- SCPH 15.00
- PAYS 22.31
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized, payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.